Détail - canceropole-wordpress

Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review.

Pillot V, Toquet S, Charuel JL, Tansley S, Boussouar S, Brillet PY, Lu H, Vellas D, Boulahfa ST, Louis SL, Uzunhan Y, Belle A, Cohen P, Ghillani-Dalbin P, Miyara M, Hie M, Foulon G, Gambier N, Boitiaux JF, Fuzibet P, Crestani B, Baudelet L, Ilzkovitz M, Nagant C, Bouvier AM, Jooste V, Benveniste O, Allenbach Y

Autoimmun Rev. 2026 03 11;:104032

More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: a French population-based study from Francim network of cancer registries.

Lamy S, Jooste V, Delpierre C, Hammas K, Vigneron N, Woronoff AS, Coureau G, Tretarre B, Seigneurin A, Molinié F, Lapotre-Ledoux B, Systchenko T, Remontet L, Grosclaude P, Daubisse-Marliac L,

Fr J Urol. 2025 12 10;:103066

Epidemiological Classification Changes and Incidence of Early-Onset Colorectal Cancer.

Jooste V, Nousbaum JB, Alves A, Woronoff AS, Launoy G, Molinié F, Desandes E, Delafosse P, Tretarre B, Mercier E, Lepage C, Ghiringhelli F, Bouvier AM,

JAMA Netw Open. 2025 11 3;8(11):e2541732

Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study.

Crocetti E, Bennett D, Jooste V, Rossi S, Maso LD, Marcos-Gragera R, Smits S, Tina Z, Xavier T, Mayer-da-Silva A, Daubisse-Marliac L, Lourenço A, Katalinic A, Sanchez MJ, Vener C, Mousavi M, Ziliani V, Gatta G

Eur J Cancer. 2025 10 19;231:116061

The impact of cancer survivors' extra risk of non-cancer mortality on net survival estimation.

Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso LD, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V, Wg TE

Am J Epidemiol. 2025 08 19;:

Estimating cure and risk of death from other causes of adolescent and young adult cancer patients in Europe.

Botta L, Capocaccia R, Vener C, Bernasconi A, Trama A, Didoné F, Demuru E, De Angelis R, Rossi S, Mousavi SM, Peters F, Bennet D, Mayer-da-Silva A, Jooste V,

Eur J Cancer. 2025 04 19;222:115443

Use of mortality tables by level of deprivation in the study of social inequalities in cancer survival.

Wilson S, Merville O, Dejardin O, Gardy J, Rollet Q, Jooste V, Network F, Molinie F, Tron L, Launoy G

Eur J Epidemiol. 2025 02 6;:

Surgical patterns of care of pancreatic cancer. A French population-based study.

Goebel G, Jooste V, Molinie F, Grosclaude P, Woronoff AS, Alves A, Bouvier V, Nousbaum JB, Plouvier S, Bengrine-Lefevre L, Rabel T, Bouvier AM,

Eur J Surg Oncol. 2024 10 9;:108748

Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries.

Gardy J, Wilson S, Guizard AV, Bouvier V, Launay L, Alves A, Bara S, Bouvier AM, Coureau G, Cowppli-Bony A, Dabakuyo Yonli S, Daubisse-Marliac L, Defossez G, Hammas K, Hure F, Jooste V, Lapotre-Ledoux B, Nousbaum JB, Plouvier S, Seigneurin A, Tretarre B, Vigneron N, Woronoff AS, Launoy G, Molinie F, Bryere J, Dejardin O

Cancer. 2024 08 20;:

Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers.

Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso LD, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V,

Eur J Cancer. 2024 07 9;208:114187

Trends in incidence of infrequent and frequent synchronous metastases from colorectal cancer.

Jooste V, Lepage C, Manfredi S, Bouvier AM

Dig Liver Dis. 2024 07 6;:

Differences in survival and recurrence of colorectal cancer by stage across population-based European registries.

Bouvier AM, Jooste V, Lillini R, Marcos-Gragera R, Katalinic A, Giorgi Rossi P, Launoy G, Bouvier V, Guevara M, Ardanaz E, Rapiti Aylward E, Innos K, Barranco MR, Sant M,

Int J Cancer. 2024 04 5;:

Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based study.

Jooste V, Grosclaude P, Defossez G, Daubisse L, Woronoff AS, Bouvier V, Chirpaz E, Tretarre B, Lapotre B, Plouvier S, Launoy G, Bonneault M, Molinié F, Bouvier AM,

Dig Liver Dis. 2023 11 3;:

Biliary tract cancers have distinct epidemiological patterns and clinical characteristics according to tumour site.

Ghiringhelli F, Jooste V, Manfredi S, Hennequin A, Lepage C, Bouvier AM

HPB (Oxford). 2023 06;25(6):693-703

Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes.

Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R,

Front Oncol. 2023 04 24;13:1114701

Survival variability across hospitals after resection for pancreatic adenocarcinoma: A multilevel survival analysis on a high-resolution population-based study.

Thobie A, Bouvier AM, Bouvier V, Jooste V, Queneherve L, Nousbaum JB, Alves A, Dejardin O

Eur J Surg Oncol. 2023 04 8;:

A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data.

Botta L, Goungounga J, Capocaccia R, Romain G, Colonna M, Gatta G, Boussari O, Jooste V

BMC Med Res Methodol. 2023 03 25;23(1):70

Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies and as Risk Recurrence Factors in Stage II Colon Cancer.

Tournier B, Aucagne R, Truntzer C, Fournier C, Ghiringhelli F, Chapusot C, Martin L, Bouvier AM, Manfredi S, Jooste V, Callanan MB, Lepage C

Cancers (Basel). 2022 12 27;15(1):

Predictors of Survival in Elderly Patients with Metastatic Colon Cancer: A Population-Based Cohort Study.

Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N

Cancers (Basel). 2022 10 24;14(21):

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.

Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM

JAMA Netw Open. 2022 10 3;5(10):e2236666

Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites.

Colonna M, Grosclaude P, Bouvier AM, Goungounga J, Jooste V

Cancer. 2022 08 16;:

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.

Derangère V, Lecuelle J, Lepage C, Aoulad-Ben Salem O, Allatessem BM, Ilie A, Bouché O, Phelip JM, Baconnier M, Pezet D, Sebbagh V, Terrebonne E, Bouard G, Jooste V, Bouvier AM, Molimard C, Monnien F, Gonzalez D, Le Malicot K, Rageot D, Truntzer C, Bibeau F, Ghiringhelli F,

Eur J Cancer. 2022 07 1;172:221-230

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice.

Jooste V, Bengrine-Lefevre L, Manfredi S, Quipourt V, Grosclaude P, Facy O, Lepage C, Ghiringhelli F, Bouvier AM

Cancers (Basel). 2022 Mar 25;14(7):

Surgical treatment of digestive cancer in a well-defined elderly population.

Latrille A, Bouvier AM, Jooste V, Bengrine Lefevre L, Quipourt V, Moreno Lopez N, Facy O

Clin Res Hepatol Gastroenterol. 2021 Dec 25;:101857

Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based Study.

Tron L, Fauvernier M, Bouvier AM, Robaszkiewicz M, Bouvier V, Cariou M, Jooste V, Dejardin O, Remontet L, Alves A, Francim Group,Molinié F, Launoy G

Cancers (Basel). 2021 Oct 14;13(20):

Influence of non-clinical factors on restorative rectal cancer surgery: An analysis of four specialized population-based digestive cancer registries in France.

Thomas F, Bouvier AM, Cariou M, Bouvier V, Jooste V, Pouchucq C, Gardy J, Queneherve L, Launoy G, Alves A, Eid Y, Dejardin O

Dig Liver Dis. 2021 Jul 20;:

Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences.

Marref I, Romain G, Jooste V, Vendrely V, Lopez A, Faivre J, Gerard JP, Bouvier AM, Lepage C

Dig Liver Dis. 2021 Jun 27;:

Chemotherapy of metastatic colon cancer in France: A population-based study.

Mas L, Bachet JB, Jooste V, Lepage C, Bouvier AM

Dig Liver Dis. 2021 Apr 14;:

Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM.

Mounier M, Romain G, Callanan M, Alla AD, Boussari O, Maynadié M, Colonna M, Jooste V

J Clin Med. 2021 Apr 13;10(8):

Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study.

Bouvier AM, Jooste V, Sanchez-Perez MJ, Bento MJ, Rocha Rodrigues J, Marcos-Gragera R, Carmona-Garcia MC, Luque-Fernandez MA, Minicozzi P, Bouvier V, Innos K, Sant M,

Dig Liver Dis. 2021 Feb 23;:

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.

Guilloteau A, Abrahamowicz M, Boussari O, Jooste V, Aparicio T, Quantin C, Le Malicot K, Binquet C

BMC Med Res Methodol. 2021 Jan 9;21(1):14

Cancer cure for 32 cancer types: results from the EUROCARE-5 study.

Dal Maso L, Panato C, Tavilla A, Guzzinati S, Serraino D, Mallone S, Botta L, Boussari O, Capocaccia R, Colonna M, Crocetti E, Dumas A, Dyba T, Franceschi S, Gatta G, Gigli A, Giusti F, Jooste V, Minicozzi P, Neamtiu L, Romain G, Zorzi M, De Angelis R, Francisci S,

Int J Epidemiol. 2020 Sep 28;:

Modeling excess hazard with time-to-cure as a parameter.

Boussari O, Bordes L, Romain G, Colonna M, Bossard N, Remontet L, Jooste V

Biometrics. 2020 Aug 31;:

Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: a classic skin rash with a necrotizing myositis and high risk of malignancy.

Monseau G, Landon-Cardinal O, Stenzel W, Schoindre Y, Mariampillai K, Barete S, Martel C, Masseau A, Meyer A, Terrier B, Guégan S, Verneuil L, Audia S, Livideanu CB, Hachulla E, Kahn JE, Lefevre G, Maurier F, Moulis G, Papo T, Dossier A, Descamps V, Salort-Campana E, Richard MA, Bergot E, Mortier L, Costedoat-Chalumeau N, Genot S, Perez F, Piette AM, Samson M, Schleinitz N, Zénone T, Lacoste M, de Boysson H, Madaule S, Rigolet A, Champtiaux N, Hervier B, Bouvier AM, Jooste V, Léonard-Louis S, Maisonobe T, Aouba A, Benveniste O, Bienvenu B, Allenbach Y,

J. Am. Acad. Dermatol.. 2020 Mar 31;:

Long-Term Relative Survival after Stroke: The Dijon Stroke Registry.

Romain G, Mariet AS, Jooste V, Duloquin G, Thomas Q, Durier J, Giroud M, Quantin C, Béjot Y

Neuroepidemiology. 2019 Dec 19;:1-8

Trends in incidence of small bowel cancer according to histology: a population-based study.

Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB,

J. Gastroenterol.. 2019 Oct 19;:

Net survival in recurrence-free colon cancer patients.

Drouillard A, Bouvier AM, Boussari O, Romain G, Manfredi S, Lepage C, Faivre J, Jooste V

Cancer Epidemiol. 2019 Jun 15;61:124-128

Time-to-cure and cure proportion in solid cancers in France. A population based study.

Romain G, Boussari O, Bossard N, Remontet L, Bouvier AM, Mounier M, Iwaz J, Colonna M, Jooste V,

Cancer Epidemiol. 2019 Mar 29;60:93-101

Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer.

Jooste V, Bouvier AM, Bossard N, Uhry Z, Coureau G, Remontet L, Dantony E,

Eur J Gastroenterol Hepatol. 2019 Mar 1;:

[Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].

Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, ,

Bull Cancer. 2019 Mar 1;:

Time trends and short term projections of cancer prevalence in France.

Colonna M, Boussari O, Cowppli-Bony A, Delafosse P, Romain G, Grosclaude P, Jooste V,

Cancer Epidemiol. 2018 Aug 17;56:97-105

Patterns of care and outcomes in oesophageal cancer.

Jooste V, Manfredi S, Napoleon M, Drouillard A, Marref I, Bedenne L, Faivre J, Bouvier AM

Dig Liver Dis. 2018 Jul 20;:

Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.

Bretagne CH, Jooste V, Guenat D, Riethmuller D, Bouvier AM, Bedgedjian I, Prétet JL, Valmary-Degano S, Mougin C

J Gynecol Obstet Hum Reprod. 2018 May 25;:

Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.

Willem H, Jooste V, Boussari O, Romain G, Bouvier AM

Eur. J. Cancer Prev.. 2018 May 5;:

A new approach to estimate time-to-cure from cancer registries data.

Boussari O, Romain G, Remontet L, Bossard N, Mounier M, Bouvier AM, Binquet C, Colonna M, Jooste V

Cancer Epidemiol. 2018 Apr;53:72-80

Time trends in colorectal cancer early postoperative mortality. A French 25-year population-based study.

Manfredi S, Jooste V, Gay C, Faivre J, Drouillard A, Bouvier AM

Int J Colorectal Dis. 2017 Dec;32(12):1725-1731

Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population.

Lopez A, Bouvier AM, Jooste V, Cottet V, Romain G, Faivre J, Manfredi S, Lepage C

Gut. 2017 Oct 26;:

Current use of MRI in patients with liver metastatic colorectal cancer: a population-based study.

Pech L, Cercueil JP, Jooste V, Krause D, Facy O, Bouvier AM

Eur J Gastroenterol Hepatol. 2017 Jul;:

Focus on an unusual rise in pancreatic cancer incidence in France.

Bouvier AM, Uhry Z, Jooste V, Drouillard A, Remontet L, Launoy G, Leone N,

Int J Epidemiol. 2017 Jun;:

A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera.

Enblom-Larsson A, Girodon F, Bak M, Hersby D, Jooste V, Hasselbalch H, Johansson P, Andreasson B

Br. J. Haematol.. 2017 May;:

Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma.

Amiot A, Jooste V, Gagniere C, Lévy M, Copie-Bergman C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Bouvier AM, Delchier JC

Leuk. Lymphoma. 2017 Jan;:1-11

Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study.

Faivre J, Bossard N, Jooste V,

Eur. J. Cancer Prev.. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S40-S47

Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population.

Chapelle N, Bouvier AM, Manfredi S, Drouillard A, Lepage C, Faivre J, Jooste V

Ann. Surg. Oncol.. 2016 Oct;23(11):3677-83

Pancreatic cancer: Wait times from presentation to treatment and survival in a population-based study.

Jooste V, Dejardin O, Bouvier V, Arveux P, Maynadie M, Launoy G, Bouvier AM

Int. J. Cancer. 2016 Sep;139(5):1073-80

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, Schoindre Y, Rigolet A, Gilardin L, Musset L, Charuel JL, Boyer O, Jouen F, Drouot L, Martinet J, Stojkovic T, Eymard B, Laforêt P, Behin A, Salort-Campana E, Fain O, Meyer A, Schleinitz N, Mariampillai K, Grados A, Benveniste O

Brain. 2016 Aug;139(Pt 8):2131-5

Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.

Draht MX, Smits KM, Jooste V, Tournier B, Vervoort M, Ramaekers C, Chapusot C, Weijenberg MP, van Engeland M, Melotte V

Clin Epigenetics. 2016 ;8:44

Liver fat content is negatively associated with atherosclerotic carotid plaque in type 2 diabetic patients.

Loffroy R, Terriat B, Jooste V, Robin I, Brindisi MC, Hillon P, Vergès B, Cercueil JP, Petit JM

Quant Imaging Med Surg. 2015 Dec;5(6):792-8

Incidence and patterns of late recurrences in colon cancer patients.

Bouvier AM, Launoy G, Bouvier V, Rollot F, Manfredi S, Faivre J, Cottet V, Jooste V

Int J Cancer. 2015 Nov 1;137(9):2133-8

Erratum to: Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population.

Chapelle N, Manfredi S, Lepage C, Faivre J, Bouvier AM, Jooste V

Gastric Cancer. 2015 Oct 7.

Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: A population-based study.

Fournier E, Jooste V, Woronoff AS, Quipourt V, Bouvier AM, Mercier M

Dig Liver Dis. 2015 Sep 28. pii: S1590-8658(15)00619-2

Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.

Quere P, Facy O, Manfredi S, Jooste V, Faivre J, Lepage C, Bouvier AM

Dis Colon Rectum. 2015 Aug;58(8):743-52

Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study.

Drouillard A, Bouvier AM, Rollot F, Faivre J, Jooste V, Lepage C

Dig Liver Dis. 2015 Jul;47(7):597-601

Factors influencing inclusion in digestive cancer clinical trials: A population-based study.

Frerot M, Jooste V, Binquet C, Fournel I, Bedenne L, Bouvier AM

Dig Liver Dis. 2015 May 28. pii: S1590-8658(15)00346-1

Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study.

Bouvier AM, Belot A, Manfredi S, Jooste V, Uhry Z, Faivre J, Duport N, Grabar S

Eur J Cancer Prev. 2015 May 11.

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis.

Petit JM, Pedro L, Guiu B, Duvillard L, Bouillet B, Jooste V, Habchi M, Crevisy E, Fourmont C, Buffier P, Hillon P, Cercueil JP, Verges B

Diabet Med. 2015 May 16

Incidence and patterns of late recurrences in rectal cancer patients.

Cottet V, Bouvier V, Rollot F, Jooste V, Bedenne L, Faivre J, Launoy G, Bouvier AM

Ann Surg Oncol. 2015 Feb;22(2):520-7

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer.

Manceau G, Marisa L, Boige V, Duval A, Gaub MP, Milano G, Selves J, Olschwang S, Jooste V, le Legrain M, Lecorre D, Guenot D, Etienne-Grimaldi MC, Kirzin S, Martin L, Lepage C, Bouvier AM, Laurent-Puig P

Cancer Med. 2015 Feb 2

Incidence and survival in late liver metastases of colorectal cancer.

Landreau P, Drouillard A, Launoy G, Ortega-Deballon P, Jooste V, Lepage C, Faivre J, Facy O, Bouvier AM

J. Gastroenterol. Hepatol.. 2015 Jan;30(1):82-5

Trends in the management of gastric cancer over a 32-year period: a French population-based study.

Herbreteau E, Jooste V, Hamza S, Lepage C, Faivre J, Bouvier AM

Gastric Cancer. 2015 Jan;18(1):129-37

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, De Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pelissier S, Collette L

Eur J Cancer. 2014 Nov;50(17):2983-93

The influence of geographical access to health care and material deprivation on colorectal cancer survival: evidence from France and England.

Dejardin O, Jones AP, Rachet B, Morris E, Bouvier V, Jooste V, Coombes E, Forman D, Bouvier AM, Launoy G

Health Place. 2014 Nov;30:36-44

Guidelines for time-to-event endpoint definitions in sarcomas and gastro-intestinal stromal tumors (GIST) trials. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

Bellera CA, Penel N, Ouali M, Bonvalot S, Casalli PG, Nielsen OS, Delannes M, Litiere S, Bonnetain F, Dabakuyo TS, Benjamin R, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Pechoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijder S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pelissier S

Ann Oncol. 2014 Jul 28. pii: mdu360.

Management of rectal cancer in France in a well-defined population.

Desgrippes R, Bouvier V, Delafosse P, Robaszkiewicz M, Molinie F, Tretarre B, Lepage C, Faivre J, Jooste V, Bouvier AM

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):743-7

CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.

Cleven AH, Derks S, Draht MX, Smits KM, Melotte V, Van Neste L, Tournier B, Jooste V, Chapusot C, Weijenberg MP, Herman JG, de Bruine AP, van Engeland M

Clin Cancer Res. 2014 Jun 15;20(12):3261-71

Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.

Draht MX, Smits KM, Tournier B, Jooste V, Chapusot C, Carvalho B, Cleven AH, Derks S, Wouters KA, Belt EJ, Stockmann HB, Bril H, Weijenberg MP, van den Brandt PA, de Bruine AP, Herman JG, Meijer GA, Piard F, Melotte V, van Engeland M

Mol Oncol. 2014 May;8(3):679-88

Rural-urban differences in the long-term risk of colorectal cancer after adenoma removal: a population-based study.

Fournel I, Cottet V, Binquet C, Jooste V, Faivre J, Bouvier AM, Bonithon-Kopp C

Dig Liver Dis. 2014 Apr;46(4):376-82

Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies?

Mitry E, Rollot F, Jooste V, Guiu B, Lepage C, Ghiringhelli F, Faivre J, Bouvier AM

Eur J Cancer. 2013 Sep;49(13):2919-25

Unbiased estimates of long-term net survival of solid cancers in France.

Jooste V, Grosclaude P, Remontet L, Launoy G, Baldi I, Molinie F, Arveux P, Bossard N, Bouvier AM, Colonna M

Int J Cancer. 2013 May 15;132(10):2370-7

Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997-2004.

Dejardin O, Rachet B, Morris E, Bouvier V, Jooste V, Haynes R, Coombes EG, Forman D, Jones AP, Bouvier AM, Launoy G

Br J Cancer. 2013 Mar 5;108(4):775-83

Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.

Bonicelli G, Abdulkarim K, Mounier M, Johansson P, Rossi C, Jooste V, Andreasson B, Maynadie M, Girodon F

Br J Haematol. 2013 Jan;160(2):251-4

Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).

Peyrin-Biroulet L, Lepage C, Jooste V, Gueant JL, Faivre J, Bouvier AM

Inflamm Bowel Dis. 2012 Dec;18(12):2247-51

The impact of additional life-table variables on excess mortality estimates.

Graffeo N, Jooste V, Giorgi R

Stat Med. 2012 Dec 30;31(30):4219-30

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.

Petit JM, Guiu B, Duvillard L, Jooste V, Brindisi MC, Athias A, Bouillet B, Habchi M, Cottet V, Gambert P, Hillon P, Cercueil JP, Verges B

Clin Nutr. 2012 Aug;31(4):520-5

Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study.

Cottet V, Jooste V, Fournel I, Bouvier AM, Faivre J, Bonithon-Kopp C

Gut. 2012 Aug;61(8):1180-6

Volume of surgical activity and lymph node evaluation for patients with colorectal cancer in France.

Dejardin O, Ruault E, Jooste V, Pornet C, Bouvier V, Bouvier AM, Launoy G

Dig Liver Dis. 2012 Mar;44(3):261-7

Chronic viral hepatitis and risk of lymphoid malignancies: a retrospective twelve-year population-based cohort study in Cote d'Or, France.

Proby C, Minello A, Quantin C, Jooste V, Binquet C, Hagi M, Mounier M, Benzenine E, Hillon P, Maynadie M

Dig Liver Dis. 2012 Feb;44(2):160-5

Rural-urban inequalities in detection rates of colorectal tumours in the population.

Fournel I, Cottet V, Binquet C, Jooste V, Faivre J, Bouvier AM, Bonithon-Kopp C

Dig Liver Dis. 2012 Feb;44(2):172-7

PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.

Petit JM, Guiu B, Masson D, Duvillard L, Jooste V, Buffier P, Bouillet B, Brindisi MC, Robin I, Gambert P, Verges B, Cercueil JP, Hillon P

Liver Int. 2011 Oct;31(9):1332-6

Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010.

Jooste V, Remontet L, Colonna M, Belot A, Launoy G, Binder F, Faivre J, Bouvier AM

Eur J Cancer Prev. 2011 Sep;20(5):375-80.

Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study.

Quipourt V, Jooste V, Cottet V, Faivre J, Bouvier AM

J Am Geriatr Soc. 2011 Apr;59(4):694-8

Competing risk models to estimate the excess mortality and the first recurrent-event hazards.

Belot A, Remontet L, Launoy G, Jooste V, Giorgi R

BMC Med Res Methodol. 2011 May 25;11:78.

Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population.

Chauvenet M, Cottet V, Lepage C, Jooste V, Faivre J, Bouvier AM

BMC Cancer. 2011 Jun 30;11:282.

Age-period-cohort analysis of stroke incidence in Dijon from 1985 to 2005.

Khellaf M, Quantin C, d'Athis P, Fassa M, Jooste V, Hervieu M, Giroud M, Bejot Y

Stroke. 2010 Dec;41(12):2762-7

Rising incidence of pancreatic cancer in France.

Bouvier AM, David M, Jooste V, Chauvenet M, Lepage C, Faivre J

Pancreas. 2010 Nov;39(8):1243-6.

Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study.

Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM

Gut. 2010 Oct;59(10):1383-8

Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia.

Droin N, Jacquel A, Hendra JB, Racoeur C, Truntzer C, Pecqueur D, Benikhlef N, Ciudad M, Guery L, Jooste V, Dufour E, Fenaux P, Quesnel B, Kosmider O, Fontenay M, Ducoroy P, Solary E

Blood. 2010 Jan 7;115(1):78-88

Immunogenic death of colon cancer cells treated with oxaliplatin.

Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L, Mendiboure J, Pignon JP, Jooste V, van Endert P, Ducreux M, Zitvogel L, Piard F, Kroemer G

Oncogene. 2010 Jan 28;29(4):482-91

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.

Kosmider O, Gelsi-Boyer V, Ciudad M, Racoeur C, Jooste V, Vey N, Quesnel B, Fenaux P, Bastie JN, Beyne-Rauzy O, Stamatoulas A, Dreyfus F, Ifrah N, de Botton S, Vainchenker W, Bernard OA, Birnbaum D, Fontenay M, Solary E

Haematologica. 2009 Dec;94(12):1676-81